Treatment of Allergic Patients with Adenotonsillar Hypertrophy: Surgery Versus Medication Therapy

  • Mahnaz Sadeghi Shabestari Immunology Research Center, TB and Lung Disease Research Center of Tabriz, Children Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
  • Yalda Jabbari Moghaddam Department of Otorhinolaryngology, School of Medicine, Sina Medical Research and Training Hospital, Children Medical Research and Training Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
  • Navid Kalani Research Center for Noncommunicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran
  • Fariborz Brumdanpur Department of Otorhinolaryngology, School of Medicine, Sina Medical Research and Training Hospital, Children Medical Research and Training Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
  • Amin Dakhili Ardestani Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran
  • Mojtaba Sohrabpour Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
DOI: https://doi.org/10.31661/gmj.v11i.2317
Keywords: Allergic, Adenotonsillar Hypertrophy, Medication, Tonsillectomy

Abstract

Background: Adenotonsillar hypertrophy (AH) is the most common cause of respiratory obstruction of the upper airway, and tonsillectomy is one of the most frequently performed surgical interventions in children. It has been proposed that medical treatment in an allergic state could decrease the size of AH. Therefore, this study aimed to compare the outcomes of surgery and medical therapies among allergic children with AH. Materials and Methods: This case-control study was carried out on 68 children with AH in an allergic state who were referred to the Pediatrics Hospital of Tabriz Medical University. They were divided into two groups and matched according to sex, age, and primary clinical signs and symptoms. Patients received surgery (case group) and medication (control groups) for treated AH. Finally, they were compared according to the results of treatment and recurrence rate. Results: The mean age of children in the case and control groups was 6.3±2.3 and 6.8±2.1 years, respectively. There was no significant difference in improving clinical signs and symptoms between the two groups. In the case group, no improvement of clinical signs and symptoms was observed in one patient compared with two patients in the control group. In the control group, no decrease in the size of the tonsils was observed in three patients. Recurrence of clinical signs of AH was observed in six (17.6%) patients of the control group, and there was a significant difference between the two groups (P<0.001). Conclusion: Our findings showed no significant differences in the outcomes of the two therapeutic methods for AH in an allergic state. However, medical treatment needs a long time to affect, but surgery can act quickly. Recurrence of AH after medical therapy could occur.

References

Brambilla I, Pusateri A, Pagella F, Caimmi D, Caimmi S, Licari A, et al. Adenoids in children: advances in immunology, diagnosis, and surgery. Clin Anat. 2014;27(3):346-52.

https://doi.org/10.1002/ca.22373

PMid:24535951

Brambilla I, Manti S, Savasta S, Valsecchi C, Caimmi SM, Marseglia GL, et al. Adenoidal Immune Response in the Context of Inflammation and Allergy. Current Respiratory Medicine Reviews. 2019;15(3):231-7.

https://doi.org/10.2174/1573398X15666190703110843

Buskens E, Van Staaij B, Van Den Akker J, Hoes AW, Schilder AG. Adenotonsillectomy or watchful waiting in patients with mild to moderate symptoms of throat infections or adenotonsillar hypertrophy: a randomized comparison of costs and effects. Arch Otolaryngol Head Neck Surg. 2007;133(11):1083-8.

https://doi.org/10.1001/archotol.133.11.1083

PMid:18025310

Shen L, Zheng B, Lin Z, Xu Y, Yang Z. Tailoring therapy to improve the treatment of children with obstructive sleep apnea according to grade of adenotonsillar hypertrophy. Int J Pediatr Otorhinolaryngol. 2015;79(4):493-8.

https://doi.org/10.1016/j.ijporl.2015.01.005

PMid:25649714

Colavita L, Miraglia MDG, Stroscio G, Visalli C, Alterio T, Pidone C, et al. Allergic rhinitis and adenoid hypertrophy in children: is adenoidectomy always really useful? J Biol Regul Homeost Agents. 2015;29(1):58-63.

Tatlıpınar A, Duman D, Uslu C, Egeli E. The effects of obstructive sleep apnea syndrome due to adenotonsillar hypertrophy on the cardiovascular system in children. Turk J Pediatr. 2011;53:359-63.

Orji FT, Adiele DK, Umedum NG, Akpeh JO, Ofoegbu VC, Nwosu JN. The clinical and radiological predictors of pulmonary hypertension in children with adenotonsillar hypertrophy. Eur Arch Otorhinolaryngol. 2017;274(3):1237-43.

https://doi.org/10.1007/s00405-016-4207-y

PMid:27430227

Cincin A, Sakalli E, Bakirci EM, Dizman R. Relationship between obstructive sleep apnea-specific symptoms and cardiac function before and after adenotonsillectomy in children with adenotonsillar hypertrophy. Int J Pediatr Otorhinolaryngol. 2014;78(8):1281-7.

https://doi.org/10.1016/j.ijporl.2014.05.011

PMid:24880923

Kara CO, Ergin H, Koçak G, Kılıç Il, Yurdakul M. Prevalence of tonsillar hypertrophy and associated oropharyngeal symptoms in primary school children in Denizli, Turkey. Int J Pediatr Otorhinolaryngol. 2002;66(2):175-9.

https://doi.org/10.1016/S0165-5876(02)00247-1

PMid:12393253

Karaca CT, Toros SZ, Noseri H, Kulekci S, Kalayck C, Oysu C, et al. Role of allergy in children with adenotonsillar hypertrophy. J Craniofac Surg. 2012;23(6):e611-3.

https://doi.org/10.1097/SCS.0b013e31826cf562

PMid:23172495

Pereira L, Monyror J, Almeida FT, Almeida FR, Guerra E, Flores-Mir C, et al. prevalence of adenoid hypertrophy: A systematic review and meta-analysis. Sleep Med Rev. 2018;38:101-12.

https://doi.org/10.1016/j.smrv.2017.06.001

PMid:29153763

Zhang X, Sun B, Li S, Jin H, Zhong N, Zeng G. Local atopy is more relevant than serum s Ig E in reflecting allergy in childhood adenotonsillar hypertrophy. Pediatr Allergy Immunol. 2013;24(5):422-6.

https://doi.org/10.1111/pai.12089

PMid:23724785

Venekamp RP, Hearne BJ, Chandrasekharan D, Blackshaw H, Lim J, Schilder AGM. Tonsillectomy or adenotonsillectomy versus non‐surgical management for obstructive sleep‐disordered breathing in children. Cochrane Database Syst Rev. 2015;2015(10): CD011165.

https://doi.org/10.1002/14651858.CD011165.pub2

Lou Z. Adenoid hypertrophy in children and allergic rhinitis. Eur Arch Otorhinolaryngol. 2018;275(3):831-2.

https://doi.org/10.1007/s00405-017-4737-y

PMid:28887688

Evcimik MF, Dogru M, Cirik AA, Nepesov MI. Adenoid hypertrophy in children with allergic disease and influential factors. Int J Pediatr Otorhinolaryngol. 2015;79(5):694-7.

https://doi.org/10.1016/j.ijporl.2015.02.017

PMid:25758194

Eren E, Arslanoglu S, Erdem SB, Nacaroglu T, Karkiner CS, Can D, et al. Chicken or the egg: the dilemma of allergic rhinitis versus adenoid hypertrophy. Rhinology. 2015;53(2):154-9.

https://doi.org/10.4193/Rhino14.013

PMid:26030038

Cho K-S, Kim SH, Hong S-L, Lee J, Mun SJ, Roh YE, et al. Local atopy in childhood adenotonsillar hypertrophy. Am J Rhinol Allergy. 2018;32(3):160-6.

https://doi.org/10.1177/1945892418765003

PMid:29649882

Kuhle S, Hoffmann DU, Mitra S, Urschitz MS. Anti‐inflammatory medications for obstructive sleep apnoea in children. Cochrane Database Syst Rev. 2020;1(1):CD007074.

https://doi.org/10.1002/14651858.CD007074.pub3

PMid:31978261 PMCid:PMC6984442

Kar M, Altıntoprak N, Muluk NB, Ulusoy S, Bafaqeeh SA, Cingi C. Antileukotrienes in adenotonsillar hypertrophy: a review of the literature. Eur Arch Otorhinolaryngol 2016;273(12):4111-7.

https://doi.org/10.1007/s00405-016-3983-8

PMid:26980339

Kheirandish-Gozal L, Kim J, Goldbart AD, Gozal D. Novel pharmacological approaches for treatment of obstructive sleep apnea in children. Expert Opin Investig Drugs. 2013;22(1):71-85.

https://doi.org/10.1517/13543784.2013.735230

PMid:23126687

Sakarya E, Muluk NB, Sakalar E, Senturk M, Aricigil M, Bafaqeeh S, et al. Use of intranasal corticosteroids in adenotonsillar hypertrophy. J Laryngol Otol. 2017;131(5):384-90.

https://doi.org/10.1017/S0022215117000408

PMid:28238295

Chohan A, Lal A, Chohan K, Chakravarti A, Gomber S. Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children. Int J Pediatr Otorhinolaryngol. 2015;79(10):1599-608.

https://doi.org/10.1016/j.ijporl.2015.07.009

PMid:26235732

Zhang L, Mendoza‐Sassi RA, César JA, Chadha NK. Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy. Cochrane Database Syst Rev. 2008;2008(3):CD006286.

https://doi.org/10.1002/14651858.CD006286.pub2

PMid:18646145 PMCid:PMC8923350

Criscuoli G, D'Amora S, Ripa G, Cinquegrana G, Mansi N, Impagliazzo N, et al. Frequency of surgery among children who have adenotonsillar hypertrophy and improve after treatment with nasal beclomethasone. Pediatrics. 2003;111(3):e236-8.

https://doi.org/10.1542/peds.111.3.e236

PMid:12612277

Ciprandi G, Varricchio A, Capasso M, Varricchio A, De Lucia A, Ascione E, et al. Intranasal flunisolide treatment in children with adenoidal hypertrophy. Int J Immunopathol Pharmacol. 2007;20(4):833-6.

https://doi.org/10.1177/039463200702000420

PMid:18179756

Huang S-W, Giannoni C. The risk of adenoid hypertrophy in children with allergic rhinitis. Ann Allergy Asthma Immunol. 2001;87(4):350-5.

https://doi.org/10.1016/S1081-1206(10)62251-X

PMid:11686429

Modrzyński M, Zawisza E. Frequency of adenoid hypertrophy in children with allergic diseases. Przegl Lek. 2003;60(5):322-4.

Joshua B, Bahar G, Sulkes J, Shpitzer T, Raveh E. Adenoidectomy: long-term follow-up. Otolaryngol Head Neck Surg. 2006;135(4):576-80.

https://doi.org/10.1016/j.otohns.2006.05.027

PMid:17011420

Griffin JL, Ramadan HH, Adham RE. Prevalence of IgE-mediated hypersensitivity in children with adenotonsillar disease. Arch Otolaryngol Head Neck Surg. 1994;120(2):150-3.

https://doi.org/10.1001/archotol.1994.01880260022005

PMid:8297571

Scadding G. Non‐surgical treatment of adenoidal hypertrophy: the role of treating IgE‐mediated inflammation. Pediatr Allergy Immunol. 2010;21(8):1095-106.

https://doi.org/10.1111/j.1399-3038.2010.01012.x

PMid:20609137

Published
2022-12-13
How to Cite
Sadeghi Shabestari, M., Jabbari Moghaddam, Y., Kalani, N., Brumdanpur, F., Dakhili Ardestani, A., & Sohrabpour, M. (2022). Treatment of Allergic Patients with Adenotonsillar Hypertrophy: Surgery Versus Medication Therapy. Galen Medical Journal, 11, e2317. https://doi.org/10.31661/gmj.v11i.2317
Issue
Vol. 11 (2022): 2022
Section
Original Article

Copyright (c) 2022 Galen Medical Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).